ES2068739A1 - Inhibidores retrovirables de proteasas. - Google Patents

Inhibidores retrovirables de proteasas.

Info

Publication number
ES2068739A1
ES2068739A1 ES09300107A ES9300107A ES2068739A1 ES 2068739 A1 ES2068739 A1 ES 2068739A1 ES 09300107 A ES09300107 A ES 09300107A ES 9300107 A ES9300107 A ES 9300107A ES 2068739 A1 ES2068739 A1 ES 2068739A1
Authority
ES
Spain
Prior art keywords
proteases
retroviral
retroviral inhibitors
hiv
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09300107A
Other languages
English (en)
Other versions
ES2068739B1 (es
Inventor
Thomas J Carr
Peter Lawrence Demarsh
Geoffrey B Dreyer
Ashley Edward Fenwick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to ES9300107A priority Critical patent/ES2068739B1/es
Publication of ES2068739A1 publication Critical patent/ES2068739A1/es
Application granted granted Critical
Publication of ES2068739B1 publication Critical patent/ES2068739B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

INHIBIDORES RETROVIRALES DE PROTEASAS. ESTOS COMPUESTOS TIENEN LA FORMULA FORMULA EN DONDE RBS1 SC, RBS2 SC, RBS3 SC, RBS4 SC Y RBS5 SC SIGNIFICAN DIVERSOS RADICALES ORGANICOS O INORGANICOS. SE UTILIZAN PARA EL TRATAMIENTO DE ENFERMEDADES RETROVIRALES, INCLUYENDO EL TRATAMIENTO DE ESTADOS DE ENFERMEDAD ASOCIADOS CON VIRUS DE LA INMUNODEFICIENCIA HUMANA (HIV-1, HIV-II).
ES9300107A 1993-01-21 1993-01-21 Inhibidores retrovirables de proteasas. Expired - Fee Related ES2068739B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9300107A ES2068739B1 (es) 1993-01-21 1993-01-21 Inhibidores retrovirables de proteasas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9300107A ES2068739B1 (es) 1993-01-21 1993-01-21 Inhibidores retrovirables de proteasas.

Publications (2)

Publication Number Publication Date
ES2068739A1 true ES2068739A1 (es) 1995-04-16
ES2068739B1 ES2068739B1 (es) 1995-11-01

Family

ID=8280526

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9300107A Expired - Fee Related ES2068739B1 (es) 1993-01-21 1993-01-21 Inhibidores retrovirables de proteasas.

Country Status (1)

Country Link
ES (1) ES2068739B1 (es)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010442A1 (en) * 1990-01-09 1991-07-25 Smithkline Beecham Corporation Hiv protease inhibitors
WO1993002057A1 (en) * 1991-07-17 1993-02-04 Smithkline Beecham Corporation Retroviral protease inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010442A1 (en) * 1990-01-09 1991-07-25 Smithkline Beecham Corporation Hiv protease inhibitors
WO1993002057A1 (en) * 1991-07-17 1993-02-04 Smithkline Beecham Corporation Retroviral protease inhibitors

Also Published As

Publication number Publication date
ES2068739B1 (es) 1995-11-01

Similar Documents

Publication Publication Date Title
AU1808488A (en) Compounds for the treatment of alzheimer's disease
FI964773A0 (fi) (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa
BR9812837A (pt) Processo para fazer um composto, e, composto
DE122006000010I2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in derBehandlung von kardiovaskularen Krankheiten
DE69433784D1 (de) 9-(Substituiertes Glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxytetracycline
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
NO304884B1 (no) 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav
FI964771A0 (fi) (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa
BR9808923A (pt) Composto, e, processo para fazer o mesmo
DK671588D0 (da) Bisphenylalkylpiperazinderivater og fremgangsmaade til fremstilling deraf
ES2159287T3 (es) Peptidos hemorreguladores.
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
ES2068739A1 (es) Inhibidores retrovirables de proteasas.
ATE139442T1 (de) Neue verwendung von linomide (r)
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
OA08973A (fr) Butyl hydroxyanisoles pour le traitement des maladies à rétro-virus
ZA961897B (en) 6,7-substituted-2-aminotetralines and use thereof
DE69214647D1 (de) Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz
CA2155129A1 (en) Combinations of Retroviral Inhibitors
DZ1667A1 (fr) Déphosphatation biologique des eaux usées.
LTIP1943A (en) Arylating agents, used in the treatment of cancerand disease caused by viral infection
IT1265251B1 (it) Derivati iodurati del bifenile e loro impiego diagnostico

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040916